ROIV
Income statement / Annual
Last year (2025), Roivant Sciences Ltd's total revenue was $8.26 M,
a decrease of 71.57% from the previous year.
In 2025, Roivant Sciences Ltd's net income was -$299.77 M.
See Roivant Sciences Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
03/31/2026 |
03/31/2025 |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
| Operating Revenue |
$8.26 M |
$29.05 M |
$32.71 M |
$31.53 M |
$55.29 M |
$23.80 M |
$67.69 M |
| Cost of Revenue |
$1.29 M
|
$911.00 K
|
$1.60 M
|
$3.03 M
|
$8.97 M
|
$2.06 M
|
$1.13 M
|
| Gross Profit |
$6.98 M
|
$28.14 M
|
$31.11 M
|
$28.50 M
|
$46.32 M
|
$21.74 M
|
$66.56 M
|
| Gross Profit Ratio |
0.84
|
0.97
|
0.95
|
0.9
|
0.84
|
0.91
|
0.98
|
| Research and Development Expenses |
$681.81 M
|
$550.41 M
|
$439.91 M
|
$454.06 M
|
$483.04 M
|
$236.63 M
|
$263.22 M
|
| General & Administrative Expenses |
$610.47 M
|
$591.41 M
|
$416.13 M
|
$383.45 M
|
$775.03 M
|
$259.88 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$610.47 M
|
$591.41 M
|
$416.13 M
|
$383.45 M
|
$775.03 M
|
$259.88 M
|
$335.77 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$596.13 M
|
$0.00
|
| Operating Expenses |
$1.29 B
|
$1.14 B
|
$856.04 M
|
$837.51 M
|
$1.26 B
|
$1.09 B
|
$598.98 M
|
| Cost And Expenses |
$1.29 B
|
$1.14 B
|
$857.64 M
|
$840.54 M
|
$1.27 B
|
$1.09 B
|
$600.11 M
|
| Interest Income |
$178.11 M
|
$258.38 M
|
$146.43 M
|
$32.18 M
|
$369.00 K
|
$1.42 M
|
$17.99 M
|
| Interest Expense |
$0.00
|
$0.00
|
$34.78 M
|
$27.97 M
|
$7.04 M
|
$2.81 M
|
$7.68 M
|
| Depreciation & Amortization |
$3.35 M
|
$14.07 M
|
$22.04 M
|
$18.86 M
|
$5.93 M
|
$0.00
|
$0.00
|
| EBITDA |
-$261.23 M |
-$667.52 M |
$4.62 B |
-$838.17 M |
-$910.77 M |
-$895.74 M |
-$553.30 M |
| EBITDA Ratio |
-31.63
|
-22.98
|
141.37
|
-26.58
|
-16.47
|
-37.64
|
-8.17
|
| Operating Income Ratio |
-155.61
|
-38.33
|
-25.22
|
-25.66
|
-21.92
|
-45.01
|
-7.87
|
| Total Other Income/Expenses Net |
$1.02 B
|
$432.09 M
|
$5.39 B
|
-$75.98 M
|
$288.00 M
|
$172.35 M
|
-$28.56 M
|
| Income Before Tax |
-$264.58 M
|
-$681.59 M
|
$4.57 B
|
-$884.99 M
|
-$923.75 M
|
-$898.55 M
|
-$560.99 M
|
| Income Before Tax Ratio |
-32.03
|
-23.46
|
139.63
|
-28.07
|
-16.71
|
-37.76
|
-8.29
|
| Income Tax Expense |
$133.33 M
|
$48.17 M
|
$21.50 M
|
$4.08 M
|
$369.00 K
|
$1.69 M
|
$7.12 M
|
| Net Income |
-$299.77 M
|
-$171.98 M
|
$4.35 B
|
-$1.01 B
|
-$845.26 M
|
-$809.23 M
|
$1.20 B
|
| Net Income Ratio |
-36.29
|
-5.92
|
132.94
|
-32
|
-15.29
|
-34.01
|
17.74
|
| EPS |
-0.43 |
-0.24 |
5.55 |
-1.42 |
-1.26 |
-1.18 |
1.75 |
| EPS Diluted |
-0.43 |
-0.24 |
5.23 |
-1.42 |
-1.26 |
-1.18 |
1.75 |
| Weighted Average Shares Out |
$693.86 M
|
$725.40 M
|
$783.25 M
|
$712.79 M
|
$669.75 M
|
$684.79 M
|
$684.79 M
|
| Weighted Average Shares Out Diluted |
$693.86 M
|
$725.40 M
|
$831.05 M
|
$712.79 M
|
$669.75 M
|
$684.79 M
|
$684.79 M
|
| Link |
|
|
|
|
|
|
|
